XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 59,447 $ 49,255
Marketable securities, available for sale 51,402 33,852
Prepaid expenses and other current assets 2,720 4,857
Total current assets 113,569 87,964
Property and equipment, net 45 59
Other non-current assets 983 1,068
Total assets 114,597 89,091
Current liabilities:    
Accounts payable 344 507
Accrued expenses 2,419 3,638
Total current liabilities 2,763 4,145
Non-current liabilities:    
Long-term debt, net of discount 30,916 30,137
Total liabilities 33,679 34,282
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2024 and December 31, 2023; no shares issued or outstanding as of June 30, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 54,712,132 and 42,470,264 shares issued as of June 30, 2024 and December 31, 2023, respectively; 54,654,495 and 42,422,531 shares outstanding as of June 30, 2024 and December 31, 2023, respectively 5 4
Additional paid-in capital 298,178 250,825
Accumulated other comprehensive income (loss) (26) 9
Treasury stock, 57,637 and 47,733 shares as of June 30, 2024 and December 31, 2023, respectively; at cost (101) (59)
Accumulated deficit (217,138) (195,970)
Total stockholders' equity 80,918 54,809
Total liabilities and stockholders' equity $ 114,597 $ 89,091